Fetal androgen signaling defects affect pancreatic β-cell mass and function, leading to glucose intolerance in high-fat diet-fed male rats
Fetal androgen signaling defects affect pancreatic β-cell mass and function, leading to glucose intolerance in high-fat diet-fed male rats
复制标题
DOI:
10.1152/ajpendo.00173.2019
复制
发表时间:
2019-11-01
影响因子:
5.1
通讯作者:
Yamaji, Ryoichi
中科院分区:
文献类型:
--
作者:
Harada, Naoki;Yotsumoto, Yusuke;Yamaji, Ryoichi
We previously demonstrated that androgen signaling expands pancreatic beta-cell mass in the sexual maturation period (Am J Physiol Endocrinol Metab 314: E274-E286, 2018). The aim of this study was to elucidate whether fetal androgen signaling plays important roles in beta-cell mass development and beta-cell function in adulthood, defects of which are associated with type 2 diabetes mellitus. In the pancreas of male fetuses, androgen receptor (AR) was strongly expressed in the cytoplasm and at the cell membrane of Nkx6.1-positive beta-cell precursor cells but was markedly reduced in insulin-positive beta-cells. Administration of the anti-androgen flutamide to pregnant dams during late gestation reduced beta-cell mass and Ki67-positive proliferating beta-cells at birth in a male-specific manner without affecting body weight. The decrease of beta-cell mass in flutamide-exposed male rats was not recovered when rats were fed a standard diet, whereas it was fully recovered when rats were fed a high-fat diet (HFD), at 6 and 12 wk of age. Flutamide exposure in utero led to the development of glucose intolerance in male rats due to a decrease in insulin secretion when fed HFD but not standard diet. Insulin sensitivity did not differ between the two groups irrespective of diet. These results indicated that the action of fetal androgen contributed to beta-cell mass expansion in a sex-specific manner at birth and to the development of glucose intolerance by decreasing the secretion of insulin in HFD-fed male rats. Our data demonstrated the involvement of fetal androgen signaling in hypothesized sex differences in the developmental origins of health and disease by affecting pancreatic beta-cell function.